D-922-2013 Class I Terminated
FDA drug recall D-922-2013 was initiated by Hospira Inc. on Aug 31, 2012 and is designated Class I. Reason for recall: Presence of Particulate Matter; product may contain fibrous material The recall status is terminated (terminated May 28, 2015). Affected quantity: 264,432 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 4, 2013
- Initiation Date
- Aug 31, 2012
- Termination Date
- May 28, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 264,432 bags
Product Description
0.9% Sodium Chloride Injection, USP, 100 mL flexible container, Rx only, Hospira, Inc. Lake Forest, IL 60045 --- NDC 0409-7984-23
Reason for Recall
Presence of Particulate Matter; product may contain fibrous material
Distribution Pattern
Nationwide
Code Information
Lot Number 05-201-JT, Expiration Date 1MAY2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-922-2013
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026